Experimental AIDS vaccine: process bioreactors

Experimental AIDS vaccine: process bioreactors


Rights Managed


Process engineer monitors production-scale bioreactors containing insect cell cultures for the production of VaxSyn, an experimental AIDS vaccine. The vaccine is an engineered, recombinant form of the HIV protein gp160, which is a precursor to one of HIV's surface proteins. VaxSyn is genetically-engineered from the baculovirus (an insect virus), with insect cell cultures used in the scale-up process. The vaccine is being developed by MicroGeneSys and is undergoing trials as a treatment of HIV- positive patients & as a potential vaccine against HIV infection.

Release details

Model release not available. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}